Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating myelodysplastic syndromes and sideroblastic anemias

Methods for treating myelodysplastic syndromes and sideroblastic anemias

US Patent 10189882 · Granted Jan 29, 2019

Estimated economic value: $28,954,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating iron overload with a BMP inhibitor2025
Methods for treating vascular eye disorders with ActRII antagonists2022
Activin-ActRII antagonists and uses for treating anemia2022
Activin-ActRII antagonists and uses for treating anemia2022
Methods and compositions for treating ulcers2022
Methods for treating myelodysplastic syndromes and sideroblastic anemias2020
Methods for treating myelodysplastic syndromes and sideroblastic anemias2020
Methods for treating vascular eye disorders with actrii antagonists2020
Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB 2019
Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide2017
Treatment of partial growth hormone insensitivity syndrome2001
Treatment of partial growth hormone insensitivity syndrome1998